Brain Cancer

Metastatic Breast Cancer

Breast Cancer

Colorectal Cancer

Gastric Cancers

Liver Cancer

Gastrointestinal Cancer

Bladder Cancer

Kidney Cancer

Prostate Cancer

Genitourinary Cancer

Cervical Cancer

Endometrial Cancer

Ovarian Cancer

Gynecologic Cancers

Head and Neck Cancers

Graft-Vs-Host Disease

Leukemia

Lymphoma

Multiple Myeloma

Myeloproliferative Neoplasms

Hematology

Lung Cancer

Pediatric Cancer

Sarcomas

Melanoma

Skin Cancer

The intersection of cardiology and oncology is greater than nurses and providers may assume, explained 2 experts.

Cardiotoxicities in Oncology Necessitate Nurse Vigilance

Sessions addressing supportive care needs for patients with cancer on early phase clinical trials appeared feasible and acceptable in a prospective study. 

Nurse-Led Sessions Enhance Supportive Care for Patients on Clinical Trials

Assessment of psychological needs and offering tailored interventions immediately after BCS helps patients with breast cancer in the outpatient setting.

Tailored Intervention Aids Distress, Recovery After Breast-Conserving Surgery

Providing education about patients’ diseases was difficult, according to 32% of registered nurses and 29% of infusion nurses.

Oncology Nurses Report Heavier Workloads in the Wake of the COVID-19

News

Latest News

FDA News

Adverse Event Management

Supportive Care

Disparities in Cancer Care

Drug Safety

Radiation Oncology

Survivorship 

Practice Management

Prevention

Contributors

Media

Expert Connections

Morning Rounds

The Vitals

Podcasts

Videos

Between the Lines

Meeting of the Minds

Training Academy

Conferences

Conference Coverage

Conference Listing

Publications

CME/CE

Continuing Education

Resources

Case-Based Digest 

Rx Road Map

Webinars

Cancer Summary Slides

MPN Symptom Management

Events

Subscribe

Partners

Articles

Amanda Brink is a nurse practitioner at the University of Texas MD Anderson Cancer Center. When she is not tending to patients in the hospital or clinic, she finds great satisfaction in crafting content to enlighten the public and her fellow nurses about a range of health topics.

Oncology nurses can support patients facing financial toxicity by offering guidance on available resources and providing emotional support.

Opinion: Crowdfunding Falls Short for Gynecologic Cancer Patients

About Us

Editorial Board

Contact Us

CancerNetwork.com

CureToday.com

OncLive.com

TargetedOnc.com

Advertise

Privacy

Terms & Conditions

Do Not Sell My Information

Oncology Nursing News

Facebook

LinkedIn

Specialty

Advanced Practice Providers

Clinical

Gynecologic Cancer

Immunotherapy

Nurse Navigation

Quality Improvement

1rem

View

Optimizing Patient Care in EGFR-Mutated NSCLC: AE Management and Supportive Care Strategies

Patient Case: AE Management in Practice With 1L IV Amivantamab

Video content above is prompted by the following:

Please present slides with patient case details and moderate brief discussion.

Panelists discuss how adverse event profiles, management strategies, and patient education approaches differ among EGFR-targeted therapies for non–small cell lung cancer, including oral tyrosine kinase inhibitors like osimertinib and infusion therapies like amivantamab, with emphasis on monitoring requirements and treatment sequencing decisions.

Optimizing EGFR-Targeted Therapy in NSCLC: Practical Management Strategies for Nurses and Physicians

Panelists discuss how venous thromboembolism risk assessment and prophylaxis decisions in patients with non–small cell lung cancer require careful consideration of individual risk factors, patient education strategies, and balanced communication about the benefits and concerns of preventive measures, particularly in the context of amivantamab therapy.

Practical Adverse Management Strategies With Intravenous Amivantamab

Panelists discuss how dermatologic toxicities from EGFR-targeted therapies can be effectively managed through a comprehensive approach combining prophylactic measures, early interventions with oral antibiotics and topical treatments, and patient education about self-management strategies.

Managing Dermatologic Toxicities with EGFR Targeted Therapies in NSCLC

Panelists discuss practical insights and learning opportunities through interactive examination of a patient case.

Patient Case: AE Management in Practice With 1L IV Amivantamab

EP: 1.Optimizing EGFR-Targeted Therapy in NSCLC: Practical Management Strategies for Nurses and Physicians

EP: 2.Practical Adverse Management Strategies With Intravenous Amivantamab

EP: 3.Managing Dermatologic Toxicities with EGFR Targeted Therapies in NSCLC

EP: 4.Patient Case: AE Management in Practice With 1L IV Amivantamab

Newsletter

Latest Conference Coverage